UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Multidomain intervention’ effective in relieving late-life depression
A research team at Ajou University Medical Center said it has discovered th...
by Lee Han-soo
|
2020-05-25 16:24
라인
GSK’s HIV treatment to get insurance benefits
GSK Korea said that Dovato, its first two-drug regimen in a single pill as ...
by Lee Han-soo
|
2020-05-25 14:55
라인
Meditoxin’s future uncertain, even as final verdict nears
A recent series of development over Medytox’s botulinum toxin is making it ...
by Jeong Sae-im
|
2020-05-25 14:38
라인
Despite decline in new virus cases, club-linked infections spread wider
Korea reported new Covid-19 cases of below 20 on Monday, but health officia...
by Shim Hyun-tai
|
2020-05-25 12:31
라인
Covid-19 kills demand for plastic surgery: survey
The new coronavirus pandemic hit medical institutions in general and plasti...
by Choi Gwang-seok
|
2020-05-25 12:24
라인
Immunis Bio files patent for shaking culture of immune cells
Immunos Bio said Thursday that it registered a patent on the shaking cultur...
by Shim Hyun-tai
|
2020-05-22 18:24
라인
SLS Bio scores nod for exporting Covid-19 test kits
SLS Bio has won approval from the Ministry of Food and Drug Safety to expor...
by Shim Hyun-tai
|
2020-05-22 17:31
라인
Fall in new Covid-19 cases hampers developing treatment
Local drug companies are making an all-out effort to increase sites for cli...
by Jeong Sae-im
|
2020-05-22 17:31
라인
Korean pharma’s Q1 performance not affected by Covid-19
Despite the global spread of the new coronavirus, the local pharmaceutical ...
by Kim Yun-mi
|
2020-05-22 17:29
라인
Chinese regulator OKs Genexine's P2 trial of glioblastoma treatment
Genexine said that China's National Medical Products Administration has...
by Lee Han-soo
|
2020-05-22 17:23
라인
JW Pharma launches long-lasting hydraulic acid filler
JW Pharmaceutical said that it has launched Hyalanse, a long-lasting hyalur...
by Lee Han-soo
|
2020-05-22 16:20
라인
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’
An infectious disease expert cautioned against the hasty interpretation of ...
by Kim Yun-mi
|
2020-05-22 15:27
라인
Alvogen’s obesity drug threatens Novo Nordisk's stronghold in Korea
Novo Nordisk’s Saxenda is facing fierce competition to keep its dominance i...
by Lee Han-soo
|
2020-05-22 15:19
라인
Despite efforts to stem cluster infections, sporadic outbreaks continue
Korea reported 20 new coronavirus cases Friday amid efforts to prevent furt...
by Shim Hyun-tai
|
2020-05-22 12:36
라인
St. Mary’s Hospital keeps treating severe blood diseases even amid Covid-19
St. Mary's Hospital, which had kept treating people suffering from hemo...
by Shim Hyun-tai
|
2020-05-21 18:10
라인
New endoscopic surgical way found to reduce pancreatitis incidence
An Inha University Hospital research team has released a paper that primary...
by Shim Hyun-tai
|
2020-05-21 17:37
라인
KMA to ask 27 countries to recognize Korean medical license
The Korean Medical Association said it would request 27 countries to allow ...
by Choi Gwang-seok
|
2020-05-21 17:10
라인
‘Too early to call Korea’s Covid-19 control success’
An infectious disease expert warned that it would be too early to conclude ...
by Choi Gwang-seok
|
2020-05-21 17:08
라인
Alvogen Korea to market Luye Pharma’s schizophrenia treatment
Alvogen Korea said that it would exclusively supply and market Luye Pharma ...
by Lee Han-soo
|
2020-05-21 17:02
라인
National Cancer Center confirms efficacy of proton treatment
The National Cancer Center has published clinical research findings, which ...
by Lee Han-soo
|
2020-05-21 17:02
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top